Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

NCT04340024 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.

NCT NCT04340024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04340024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Lead sponsor
National Cancer Centre, Singapore
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2015
Completion date
December 31, 2026
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal cancer, other cancer, prostate cancer